FDA in Hot Seat by Senators’ Demands on HCQ and HHS Pulling Rank on Tests
On August 18, 2020, Senator Ron Johnson (R-Wis.), Sen. Ted Cruz (R-Texas), and Sen. Mike Lee (R-Utah) submitted a letter to the U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn, demanding information regarding their actions taken on the use of hydroxychloroquine for COVID-19. “Physicians are concerned that the FDA’s actions regarding hydroxychloroquine (HCQ) may be directly costing lives by limiting outpatient access to this potentially beneficial treatment,” the letter stated. The senators wrote that the FDA’s actions on HCQ have “led to misinformation and confusion across the country. Some states have restricted the ability of physicians to write and pharmacies to fill HCQ and CQ prescriptions.” The senators are correct in that the FDA has done a fine job of creating confusion, as Corey’s Digs has been documenting their actions on HCQ since the beginning of this “pandemic.” This also comes on the heels of the historical 24-hour censoring…